To determine if plasma circulating HPV DNA (cHPVDNA) has potential as a non-invasive biomarker for identification and treatment monitoring of cervical intraepithelial neoplasia grades 2-3 by characterizing correlation between plasma cHPVDNA levels and cervical intraepithelial neoplasia grade prior to intervention and after excision.
Thank you for your interest, but this study is recruiting by invitation only.
United States (Nationwide)
Ashley Weiner
Radiation Oncology - Chapel Hill
Clinical or Medical
Cancer (Cervical)
Immune System/Infections
Sexual and/or Reproductive Health
Women's Health
19-2196
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
